Cargando…
ANO1-downregulation induced by schisandrathera D: a novel therapeutic target for the treatment of prostate and oral cancers
Anoctamin 1 (ANO1), a drug target for various cancers, including prostate and oral cancers, is an intracellular calcium-activated chloride ion channel that plays various physiopathological roles, especially in the induction of cancer growth and metastasis. In this study, we tested a novel compound i...
Autores principales: | Park, SeonJu, Das, Raju, Nhiem, Nguyen Xuan, Jeong, Sung Baek, Kim, Minuk, Kim, Dongguk, Oh, Hye In, Cho, Su-Hyeon, Kwon, Oh-Bin, Choi, Jae-Hyeog, Park, Chul Soon, Kim, Song-Rae, Moon, Uk Yeol, Cha, Boksik, Choi, Dong Kyu, Lee, Sungwoo, Namkung, Wan, Woo, Joohan, Seo, Yohan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232832/ https://www.ncbi.nlm.nih.gov/pubmed/37274097 http://dx.doi.org/10.3389/fphar.2023.1163970 |
Ejemplares similares
-
Diethylstilbestrol, a Novel ANO1 Inhibitor, Exerts an Anticancer Effect on Non-Small Cell Lung Cancer via Inhibition of ANO1
por: Seo, Yohan, et al.
Publicado: (2021) -
Ani9, A Novel Potent Small-Molecule ANO1 Inhibitor with Negligible Effect on ANO2
por: Seo, Yohan, et al.
Publicado: (2016) -
Novel ANO1 Inhibitor from Mallotus apelta Extract Exerts Anticancer Activity through Downregulation of ANO1
por: Seo, Yohan, et al.
Publicado: (2020) -
Inhibition of ANO1 by luteolin and its cytotoxicity in human prostate cancer PC-3 cells
por: Seo, Yohan, et al.
Publicado: (2017) -
VI-116, A Novel Potent Inhibitor of VRAC with Minimal Effect on ANO1
por: Jeon, Dongkyu, et al.
Publicado: (2022)